Evidence map›Paper›PMID 30319266›Full record

ArticleTherapeutics and clinical risk management2018

Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease.

Ming-Chun Chen, Ji-Hung Wang, Chung-Jen Lee, Bang-Gee Hsu

Abstract read
In one paragraph

Article in Therapeutics and clinical risk management, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Adipokines and Inflammation: Focus on Cardiovascular Diseases.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ming-Chun ChenDepartment of Pediatrics.
Ji-Hung WangDivision of Cardiology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
Chung-Jen LeeDepartment of Nursing, Tzu Chi University of Science and Technology, Hualien, Taiwan.
Bang-Gee HsuSchool of Medicine, Tzu Chi University, Hualien, Taiwan, gee.lily@msa.hinet.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHyperleptinemia has been independently associated with human cardiovascular (CV) diseases. Accordingly, we evaluate the association between serum leptin and future CV events in patients with coronary artery disease (CAD). PATIENTS AND

methodsThis study enrolled 98 patients with CAD from January to December 2012. The primary endpoint included incidences of major adverse CV events and hospitalization. Patients follow-up had been completed on June 30, 2017.

resultsAfter a median follow-up of 52 months, 43 CV events had occurred. Patients with CV events had higher systolic blood pressure (

conclusionSerum leptin levels could serve as a biomarker for future CV events in patients with CAD.

Indexed as

cardiovascular eventscoronary artery diseaseleptintriglyceride

Identifiers

PMID30319266
PMCPMC6171750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.